[Federal Register Volume 63, Number 220 (Monday, November 16, 1998)]
[Notices]
[Pages 63739-63740]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-30457]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee; Renewals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
renewal of certain FDA advisory committees by the Commissioner of Food 
and Drugs. The Commissioner has determined that it is in the public 
interest to renew the charters of the committees listed below for an 
additional 2 years beyond charter expiration date. The new charters 
will be in effect until the dates of expiration listed below. This 
notice is issued under the Federal Advisory Committee Act of October 6, 
1972 (Pub. L. 92-463 (5 U.S.C. app. 2)).

DATE: Authority for these committees will expire on the dates indicated 
below unless the Commissioner formally determines that renewal is in 
the public interest.


----------------------------------------------------------------------------------------------------------------
                   Name of committee                                        Date of expiration
----------------------------------------------------------------------------------------------------------------
Advisory Committee for Pharmaceutical Science            January 22, 2000
Medical Imaging Drugs Advisory Committee                 February 28, 2000
Gastrointestinal Drugs Advisory Committee                March 3, 2000
Advisory Committee for Reproductive Health Drugs         March 23, 2000
Arthritis Advisory Committee                             April 5, 2000
Veterinary Medicine Advisory Committee                   April 24, 2000
Anesthetic and Life Support Drugs Advisory Committee     May 1, 2000
Blood Products Advisory Committee                        May 13, 2000
Pulmonary-Allergy Drugs Advisory Committee               May 30, 2000
Drug Abuse Advisory Committee                            May 31, 2000
Science Advisory Board to the National Center for        June 2, 2000
 Toxicological and Research
Peripheral and Central Nervous System Drugs Advisory     June 4, 2000
 Committee
Psychopharmacologic Drugs Advisory Committee             June 4, 2000
Transmissible Spongiform Encephalopathies Advisory       June 9, 2000
 Committee
Science Board to the Food and Drug Administration        June 26, 2000
Allergenic Products Advisory Committee                   July 9, 2000
Cardiovascular and Renal Drugs Advisory Committee        August 27, 2000
Endocrinologic and Metabolic Drugs Advisory Committee    August 27, 2000
Oncologic Drugs Advisory Committee                       September 1, 2000
Anti-Infective Drugs Advisory Committee                  October 7, 2000
Dermatologic and Ophthalmic Drugs Advisory Committee     October 7, 2000
Biological Response Modifiers Advisory Committee         October 28, 2000
----------------------------------------------------------------------------------------------------------------

FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management 
Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-4820.


[[Page 63740]]


    Dated: November 5, 1998.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 98-30457 Filed 11-13-98; 8:45 am]
BILLING CODE 4160-01-F